Cogent IVF announced today it was rebranding itself as Vitelle, a combination of the words “vital” and “elle,” which is Greek for sunray.
“This brand platform will allow us to continue to deliver a forward-focused promise to our technology licensees and their customers across the United States,” says Bruno Sanches, Chief Operating Officer of Vytelle.
Vytelle is focused on bringing genetic advancement to commercial animals by implementing technology to produce more protein for the world, says Sanches. Vytelle uses a unique system for collecting oocytes without the use of hormonal stimulation from donor females, modified production protocols using serum-free culture media and unique freezing techniques that increase the success of post-thaw pregnancy initiation and sustained pregnancies.
Cogent IVF was founded in 2015 as a subsidiary of Cogent Breeding Ltd. In the fall of 2017, Wheatsheaf® Group sold a majority interest in Cogent Breeding Ltd. to ST Genetics, based in Texas. Prior to the acquisition Cogent IVF was transferred into Wheatsheaf Group ownership and has operated as an independent Wheatsheaf company, representing a strategic investment by the group into the bovine sector. This name change reinforces Vytelle’s commitment to advancing genetics, business and life.
“Even as we move forward as Vytelle, one thing that won’t change is the core of our business—the people, service and technology that is associated with Cogent IVF,” explains Sanches. “The team at Cogent IVF will remain the same under the Vytelle name with the same mission to Advance Genetics. Business. Life.”